HLNE Form 4: Director Reynoldo Vann Receives 333 Restricted Shares
Rhea-AI Filing Summary
Hamilton Lane director Reynoldo Vann received 333 restricted shares of Class A common stock on 09/16/2025 as compensation for board service under the company's Amended and Restated 2017 Equity Incentive Plan. The award was issued at no cash price and the shares vest one year from the transaction date. After the issuance, Mr. Vann directly beneficially owns 1,681 shares of Class A common stock. The Form 4 also discloses that he is the custodian of two custodial accounts holding additional Class A shares for his younger and older children. The filing was signed by an attorney-in-fact on 09/18/2025.
Positive
- Board compensation disclosed transparently: 333 restricted shares granted and vesting schedule provided
- Compliance detail: Form 4 includes transaction date, code, post-transaction beneficial ownership, and signature
Negative
- None.
Insights
TL;DR: Director received standard restricted stock award for service; vesting schedule aligns incentives with continued board service.
The 333-share restricted stock grant to a director is a routine equity-based compensation mechanism to align director incentives with shareholder interests. Vesting one year after grant encourages continued service through the next annual cycle. Reporting of custodial holdings for minor beneficiaries clarifies indirect beneficial ownership and complies with Section 16 disclosure rules. The direct ownership level (1,681 shares) and the custodial holdings are disclosed, aiding transparency but not indicating material control changes.
TL;DR: Filing properly discloses an award and custodial holdings; signatures and dates appear complete.
The Form 4 includes required elements: reporting person identification, issuer and ticker, transaction date (09/16/2025), transaction code (A) for acquisition, amount acquired (333 shares), post-transaction beneficial ownership (1,681 shares), and explanatory footnotes describing custodial accounts. The award price is reported as $0 consistent with compensation grants. The form is signed by an attorney-in-fact on 09/18/2025 which is acceptable when properly authorized. No derivative transactions or other dispositions are reported.